Medication info
Amlozal Tablet 5/50 mg (Amlodipine Besylate, Losartan Potassium)

Amlozal Tablet 5/50 mg (Amlodipine Besylate, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Jinyang Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502658 · Approved 2015.04.30 · Insurance code 650303310

Summary

Main use
Control of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Jinyang Pharmaceutical Co., Ltd.

Efficacy & effects

Control of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medicine is used for patients with essential hypertension who find it difficult to control blood pressure with either amlodipine or losartan alone. Additionally, it is effective when administered in a combination form from the onset to patients with stage 2 hypertension to reach target blood pressure. Therefore, it helps improve hypertension effectively.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so treatment should be discontinued immediately upon confirmation of pregnancy. Due to its potent blood pressure-lowering effects, hypotensive symptoms may occur when first administered to patients with low blood volume or those taking diuretics, so caution is advised. Patients allergic to any components of this medicine, those with severe liver dysfunction, severe aortic stenosis, or those in a state of shock should not take this medication. Patients with elevated potassium levels in the blood, severely impaired renal function, those on strict salt restrictions, and those with low blood volume should use this medicine cautiously. While taking this medication, side effects such as dizziness, headache, drowsiness, itching, swelling, indigestion, orthostatic hypotension may occur, so caution is advised. This medication may pose a risk of accidents due to dizziness when driving or operating dangerous machinery, so caution is necessary. Patients with impaired liver or kidney function may have increased concentrations of this medication in their body, necessitating special caution. When taken with other antihypertensive medications, it may enhance blood pressure-lowering effects, so it is necessary to follow a doctor's guideline. Grapefruit juice may increase blood pressure-lowering efficacy, so it is advisable not to take them together. Pregnant or breastfeeding women should not take this medication, and particularly in the case of a confirmed pregnancy, should stop taking it immediately. This medication is not recommended for patients under 18 years of age as safety and efficacy are not established. Overdosage may lead to severe hypotension and cardiac problems, so dosage should be strictly followed, and emergency medical attention is required in case of overdose. Store out of reach of children, and do not transfer to another container.

Side effects

Hypotension, neonatal skull hypoplasia, anuria, renal failure, oligohydramnios, fetal limb contraction, craniofacial malformation, pulmonary hypoplasia, prematurity, intrauterine growth restriction, patent ductus arteriosus, dizziness, headache, drowsiness, cerebral infarction, weakness, chest discomfort, chest pain, early satiety, peripheral edema, pitting edema, abdominal discomfort, dyspepsia, nausea, gastroesophageal reflux disease, constipation, pruritus, urticaria, palpitations, flushing, orthostatic hypotension, facial flushing, dyspnea, cough, conjunctival injection, polyuria, fatigue, edema, vertigo, abdominal pain, nausea, weakness, lethargy, pain, weight gain, weight loss, hypotension, vasculitis, tension increase, sensory decrease, sensory abnormalities, peripheral neuropathy, syncope, dysgeusia, tremor, erectile dysfunction, gynecomastia, change in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, leukopenia, thrombocytopenia, insomnia, mood changes, hair loss, increased sweating, purpura, skin discoloration, toxic epidermal necrolysis, tinnitus, visual disturbances, increased frequency of urination, urinary tract disorders, enuresis, hepatitis, jaundice, increased liver enzymes, pruritus, rash, angioedema, erythema multiforme, myocardial infarction, arrhythmia, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, erythema, papular rash, heaviness in the head, warmth sensation, impaired glucose tolerance, weakness, muscle cramps, low back pain, leg pain, congestion, upper respiratory tract infection, sinusitis, diarrhea, sinus disorder, pharyngitis, myalgia, insomnia, swelling, abdominal pain, angioedema, skin shedding phenomenon, hemolysis, facial edema, fever, orthostatic effect, angina pectoris, second-degree atrioventricular block, cerebrovascular accident, atrial fibrillation, bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation, loss of appetite, toothache, flatulence, gastritis, anemia, gout, upper limb pain, hip pain, joint swelling, knee pain, musculoskeletal pain, shoulder pain, muscular rigidity, arthralgia, arthritis, fibromyalgia, myasthenia, anxiety, anxiety disorder, ataxia, confusion, depression, nightmares, sensory decline, decreased libido, memory impairment, migraine, neuroirritability, panic disorder, sleep disorder, tremor, bronchitis, pharyngeal discomfort, nasal bleeding, rhinitis, respiratory congestion, hair loss, dermatitis, dry skin, petechial hemorrhage, erythema, photosensitivity, sweating, blurred vision, burning sensation and pain in the eyes, conjunctivitis, dysgeusia, tinnitus, visual impairment, enuresis, urethral infection, decreased blood pressure, shock symptoms, loss of consciousness, acute hepatitis, fulminant hepatitis, anaphylactic syndrome, angioedema, vasculitis, anaphylactic reaction, liver dysfunction, intestinal vascular edema, lethargy, thrombocytopenia, rhabdomyolysis, dysgeusia, dry cough, erythromelalgia, hyperkalemia, hyponatremia, ALT elevation, serum creatinine elevation, increased liver enzymes, excessive peripheral vasodilation in severe overdose, reflex tachycardia, systemic hypotension, shock state, hypotension, tachycardia, bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to protect it from air and moisture, at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medicine for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.